These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3323254)

  • 41. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use and interpretation of rheumatologic tests: a guide for clinicians.
    Moder KG
    Mayo Clin Proc; 1996 Apr; 71(4):391-6. PubMed ID: 8637264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multidot immunobinding assay for autoimmune testing: evaluation for the diagnosis and management of connective tissue diseases.
    Gordon J; Rosenthal M
    J Rheumatol; 1985 Apr; 12(2):257-64. PubMed ID: 3897533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antinuclear antibody and rheumatoid factor estimations in the diagnosis of rheumatic diseases in northern India.
    Malaviya AN; Banerjee S; Misra RN; Kaul R; Bhuyan UN
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):232-6. PubMed ID: 6335834
    [No Abstract]   [Full Text] [Related]  

  • 45. [Importance of the determination of antibodies to n-DNA in systemic lupus erythematosus and other rheumatic diseases (comparative study of radioisotope and immunoenzyme technics)].
    Riazantseva TA; Shakhanina KL; Aroian AA; Speranskiĭ AI
    Ter Arkh; 1987; 59(8):86-91. PubMed ID: 3317973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rheumatic Disease Autoantibodies in Patients with Autoimmune Thyroid Diseases.
    Nisihara R; Pigosso YG; Prado N; Utiyama SRR; De Carvalho GA; Skare TL
    Med Princ Pract; 2018; 27(4):332-336. PubMed ID: 29864750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].
    Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C
    Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305
    [No Abstract]   [Full Text] [Related]  

  • 49. [Optimizing the clinical value of polyreactive autoantibodies to double-stranded DNA].
    Haberhauer G; Chlud K; Isovits D
    Z Gesamte Inn Med; 1989 Nov; 44(21):652-4. PubMed ID: 2692314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Rheumatic disease in childhood. Clinical and pathogenetic notes].
    Vaccaro R; Ramenghi M
    Recenti Prog Med; 1971 Jun; 50(6):538-53. PubMed ID: 4944548
    [No Abstract]   [Full Text] [Related]  

  • 51. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists.
    Kavanaugh A; Tomar R; Reveille J; Solomon DH; Homburger HA
    Arch Pathol Lab Med; 2000 Jan; 124(1):71-81. PubMed ID: 10629135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
    Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
    J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
    Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
    J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies to the extractable nuclear antigens (ENA) in Pakistani patients with systemic rheumatic disease.
    Ahmed TA; Malik IA; Saleem M; Khan AA; Hameed A; Shah ST; Amin SJ; Farooqi A
    J Pak Med Assoc; 1995 Jan; 45(1):12-4. PubMed ID: 7731078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?
    Volkmann ER; Taylor M; Ben-Artzi A
    South Med J; 2012 Feb; 105(2):100-4. PubMed ID: 22267099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear matrix antibodies in rheumatic diseases.
    Kurki P; Virtanen I; Lehto VP; Helve T
    J Rheumatol; 1985 Apr; 12(2):253-6. PubMed ID: 3897532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Laboratory diagnostics in rheumatology].
    Wiik A
    Ugeskr Laeger; 2002 Jan; 164(5):610-4. PubMed ID: 11871209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L; Nozzi M; De Sanctis S; Chiarelli F
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W; Roy A; Kini U; Mullick S
    Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.